BiomX (NYSEAMERICAN:PHGE – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($1.10) per share for the quarter.
BiomX Stock Up 1.9 %
Shares of PHGE opened at $0.64 on Monday. The firm has a market cap of $11.67 million, a PE ratio of -0.20 and a beta of 1.27. BiomX has a 12-month low of $0.48 and a 12-month high of $4.99.
Wall Street Analyst Weigh In
Separately, HC Wainwright reissued a “buy” rating and set a $2.00 target price on shares of BiomX in a research note on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
See Also
- Five stocks we like better than BiomX
- How to Profit From Growth Investing
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is the S&P/TSX Index?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
